| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Director | Common Stock | 1.55K | $1.1M | $708.19 | 02 Jan 2025 | Direct |
| REGENERON PHARMACEUTICALS, INC. | Director | Non-Qualified Stock Option (right to buy) | 1.96K | 02 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS, INC. | 02 Jan 2025 | 2 | $0 | 4 | Director | 06 Jan 2025, 16:11 |
| REGN | REGENERON PHARMACEUTICALS, INC. | 02 Jan 2024 | 5 | -$568K | 4 | Director | 04 Jan 2024, 16:11 |
| REGN | REGENERON PHARMACEUTICALS, INC. | 13 Oct 2023 | 3 | -$458K | 4 | Director | 17 Oct 2023, 16:06 |
| REGN | REGENERON PHARMACEUTICALS, INC. | 03 Jan 2023 | 2 | $0 | 4 | Director | 05 Jan 2023, 15:15 |
| REGN | REGENERON PHARMACEUTICALS, INC. | 16 Mar 2022 | 3 | -$566K | 4 | Director | 18 Mar 2022, 16:14 |
| REGN | REGENERON PHARMACEUTICALS, INC. | 03 Jan 2022 | 2 | $0 | 4 | Director | 05 Jan 2022, 15:24 |
| REGN | REGENERON PHARMACEUTICALS, INC. | 13 Sep 2021 | 6 | -$258K | 4 | Director | 15 Sep 2021, 16:03 |